Cargando…

MUC16 promotes EOC proliferation by regulating GLUT1 expression

As a common malignancy in females with a higher incidence rate, epithelial ovarian cancer (EOC) is a heterogeneous disease with complexity and diversity in histology and therapeutic response. Although great progress has been made in diagnosis and therapeutic strategies, novel therapeutic strategies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fang, Zhang, Qing, Zhang, Hailing, Qiao, Xiaogai, Zhang, Xia, Zhang, Ke, Gu, Xiaoli, Wang, Lihong, Cui, Jinquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957195/ https://www.ncbi.nlm.nih.gov/pubmed/33543559 http://dx.doi.org/10.1111/jcmm.16345

Ejemplares similares

Circ SMARCA5 Inhibited Tumor Metastasis by Interacting with SND1 and Downregulating the YWHAB Gene in Cervical Cancer
por: Zhang, Xia, et al.
Publicado: (2021)

The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects
por: Peng, Peng, et al.
Publicado: (2019)

Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
por: Dai, Lan, et al.
Publicado: (2022)

High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2015)

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2020)

Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
por: Freedman, Ralph S, et al.
Publicado: (2004)

Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses
por: Chen, Zhonghua, et al.
Publicado: (2020)

CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2
por: He, Wei-Peng, et al.
Publicado: (2020)

Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance
por: Liu, Yu, et al.
Publicado: (2018)

miR-940 Upregulation Suppresses Cell Proliferation and Induces Apoptosis by Targeting PKC-δ in Ovarian Cancer OVCAR3 Cells
por: Wang, Fang, et al.
Publicado: (2017)

Androgen Plays a Carcinogenic Role in EOC via the PI3K/AKT Signaling Pathway in an AR-Dependent Manner
por: Li, Yanfang, et al.
Publicado: (2021)

Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response
por: Wang, Hao, et al.
Publicado: (2020)

BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1
por: Wang, Peng, et al.
Publicado: (2023)

MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research
por: Chen, Xin, et al.
Publicado: (2019)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)
por: Jim, Heather S.L., et al.
Publicado: (2015)

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
por: Chornokur, Ganna, et al.
Publicado: (2015)

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)
por: Hanson, Ryan L., et al.
Publicado: (2016)

Comparison of the Transmembrane Mucins MUC1 and MUC16 in Epithelial Barrier Function
por: Gipson, Ilene K., et al.
Publicado: (2014)

Glucose transporters GLUT1, GLUT3, and GLUT4 have different effects on osteoblast proliferation and metabolism
por: Arponen, Milja, et al.
Publicado: (2022)

Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases
por: Chen, Junyu, et al.
Publicado: (2021)

Concentrations of MUC16 and MUC5AC using three tear collection methods
por: Ablamowicz, Anna F., et al.
Publicado: (2017)

Cytokines as Prognostic Biomarkers of Epithelial Ovarian Cancer (EOC): A Systematic Review and Meta-Analysis
por: Fahmi, Moh Nailul, et al.
Publicado: (2021)

MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation
por: Zhang, Hailing, et al.
Publicado: (2021)

Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors
por: Zhang, Lei, et al.
Publicado: (2020)

Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer
por: Jain, Shruti, et al.
Publicado: (2022)

YAP promotes the proliferation and migration of colorectal cancer cells through the Glut3/AMPK signaling pathway
por: Jiang, Linhua, et al.
Publicado: (2021)

Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo
por: Zhang, Ming-Xing, et al.
Publicado: (2018)

MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer
por: Wu, Yuliang, et al.
Publicado: (2023)

The Effects of Divalent Cation-Chelated Prion Fibrils on the Immune Response of EOC 13.31 Microglia Cells
por: Jen, Huan-I, et al.
Publicado: (2020)

MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells
por: Zhang, Ai-Min, et al.
Publicado: (2019)

miR-552 promotes the proliferation and metastasis of cervical cancer cells through targeting MUC15 pathway
por: Zhang, Xinxin, et al.
Publicado: (2021)

miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations
por: Teng, Yue, et al.
Publicado: (2016)

CA125/MUC16 Is Dispensable for Mouse Development and Reproduction
por: Cheon, Dong-Joo, et al.
Publicado: (2009)

MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
por: Yang, Yue, et al.
Publicado: (2020)

Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
por: Haridas, Dhanya, et al.
Publicado: (2011)

MUC16：肿瘤治疗新靶点
Publicado: (2022)

Suppression of diabetic retinopathy with GLUT1 siRNA
por: You, Zhi-Peng, et al.
Publicado: (2017)

HPV16 E7 increases COX-2 expression and promotes the proliferation of breast cancer
por: Wang, Yong-Xia, et al.
Publicado: (2018)

TRIM11 promotes proliferation and glycolysis of breast cancer cells via targeting AKT/GLUT1 pathway
por: Song, WenBo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gf4rjh2otccdbh52bdbcjhd3oc